← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $113K of Replimune Group, Inc.

Sold$113,214
$20.01Price
5,658Shares
−2%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Mon, Sep 11. Filed Wed, Sep 13, 5:02 PM ET, after the close. Not investment advice.